StreetInsider.com News Articles

Elanco To Launch Elanco Ventures With $25 Million Multi-Year Commitment To Accelerate Innovation in Animal Health

Fri, 19 Jun 2026 09:30:00 -0400

New corporate venture capital platform will invest to advance therapeutics, technologies and One Health solutions

INDIANAPOLIS, IN / ACCESS Newswire / June 19, 2026 / Elanco Animal Health Incorporated (NYSE:ELAN) today announced plans to establish Elanco Ventures, a dedicated corporate venture capital (CVC) platform designed to support, invest and advance innovation in animal health.

To be backed by a $25 million multi-year commitment, Elanco Ventures will initially focus on strategic investments in therapeutic advancements and supportive technologies across the animal health sector.

"From pets to protein - the animal health industry has never been

Elanco To Launch Elanco Ventures With $25 Million Multi-Year Commitment To Accelerate Innovation in Animal Health

Fri, 19 Jun 2026 09:30:00 -0400

New corporate venture capital platform will invest to advance therapeutics, technologies and One Health solutions

"From pets to protein - the animal health industry has never been

Elanco Animal Health (ELAN) PT Raised to $32 at TD Cowen; Names Best Smidcap Idea

Thu, 18 Jun 2026 08:43:07 -0400

(Updated - June 18, 2026 8:43 AM EDT)

TD Cowen analyst Steve Scala raised the price target on Elanco Animal Health (NYSE: ELAN) to $32.00 (from $31.00) while maintaining a Buy rating. Names Best Smidcap Idea.

The analyst commented, "Seven potential blockbuster launches are key catalysts for sales growth and margin expansion. These launches augment a diversified existing portfolio - including a #1 Pet Retail position - which together are poised to drive +5% revenue and +10% EPS growth during 2025-32. Favorable Zenrelia U.S. label update or pipeline progress could add upside."

Elanco Animal Health (ELAN) PT Raised to $32 at TD Cowen; Names Best Smidcap Idea

Thu, 18 Jun 2026 08:43:07 -0400

(Updated - June 18, 2026 8:43 AM EDT)

TD Cowen analyst Steve Scala raised the price target on Elanco Animal Health (NYSE: ELAN) to $32.00 (from $31.00) while maintaining a Buy rating. Names Best Smidcap Idea.

Elanco to launch $25M venture capital fund for animal health

Thu, 18 Jun 2026 07:26:44 -0400

Elanco Animal Health Incorporated (NYSE: ELAN) announced plans to establish Elanco Ventures, a corporate venture capital platform backed by a $25 million multi-year commitment, according to a company press release.

Set to launch in late 2026, the fund will focus on early-stage companies at the Pre-Seed, Seed, and Series A stages, with an initial emphasis on therapeutic advancements and supporting technologies in the animal health sector. The platform may also explore opportunities within the broader One Health space, which encompasses animal, human, and plant health.

Eric Steager, described as an experienced corporate venture capital leader, will oversee Elanco Ventures.

Jeff Simmons, President and

Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health

Thu, 18 Jun 2026 07:26:00 -0400